alexa Novel Cancer Targeted Drug Delivery System Using LDL Pathway
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Summit on Clinical Pharmacy
December 02-03, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Fars K Alanazi
ScientificTracks Abstracts: Clinic Pharmacol Biopharm
DOI: 10.4172/2167-065X.S1.006
Cancer is one of the leading causes of death in USA and many pathways have been searched to deliver anticancer pharmaceuticals selectively to the tumor tissues. Nevertheless, most of available chemotherapy medications, the first line of cancer treatment modalities, are suffering from lack of targeting capabilities that leads to life threatening side effect or lowest efficacy. The importance of low-density lipoprotein (LDL) will be highlight andits implications in the field of drug delivery to cancer cells aregoing to be explored. LDL is naturally occurring bio-nanoparticles (BNP) with sizing of 25 nm. These BNPs particularlyship cholesterol to cells expressing the LDL receptors. Numerous tumors overexpress LDL receptor, to provide cholesterol for supportingthe high rate of membrane synthesis. LDL BNPs are biocompatible and biodegradable, selectively bind hydrophobic and amphiphilic drugs, are taken up by a receptor-mediated mechanism Drugs can be loaded onto LDL BNPs by surface loading, core loading, and apoprotein interaction. Therefore, LDL may be used as a drug carrier for treatment of cancer. The presentation will emphasize on the concept of drug targeting and rational for the development of targeted drug delivery systems based on lipoprotein pathway. It also will cover research reports of targeted drug delivery systems and their development basedon lipoproteins pathways. Cancer chemotherapy will be used as an example of special area of need for selective and targeted drug delivery.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version